Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03908736 · ClinicalTrials.gov registry record · NA
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
A NA study of Immune System Disorder and DNA Damage, sponsored by University of New Mexi.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03908736: Recruiting NA study of Immune System Disorder and DNA Damage, sponsored by University of New Mexi.
NCT03908736 is a NA study of Immune System Disorder and DNA Damage that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03908736, a NA study of Immune System Disorder and DNA Damage, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.
Primary Outcome
urinary and serum metal levels to be measured by inductively coupled plasma mass spectrometry
Conditions Studied
Interventions
- DRUG Zinc Picolinate 15 Mg
Study Locations (1)
New Mexico
- University of New Mexico Health Sciences Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-05-19 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT03908736 shows while recruiting
NCT03908736 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Immune System Disorder appearing as the primary indexed condition, and to 1 intervention - of which Zinc Picolinate 15 Mg is the first listed.
NCT03908736 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT03908736 about?
NCT03908736 is a clinical study titled "Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation". This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.
What is the current status of trial NCT03908736?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-05-19. Estimated completion is 2027-12.
What conditions does trial NCT03908736 study?
This clinical trial studies the following conditions: Immune System Disorder, DNA Damage.
What interventions are being tested in trial NCT03908736?
The interventions under investigation include: Zinc Picolinate 15 Mg (DRUG).
Who is sponsoring clinical trial NCT03908736?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03908736 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune System Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03908736's enrollment target sits among peer trials
100 841st of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI